Literature DB >> 26625802

Postoperative Serum CEA Level is a More Significant Prognostic Factor than Post/Preoperative Serum CEA Ratio in Non-small Cell Cancer Patients.

Masaki Tomita1, Takanori Ayabe, Eiichi Chosa, Kunihide Nakamura.   

Abstract

BACKGROUND: In non-small cell lung cancer (NSCLC) patients with preoperative high serum carcinoembryonic antigen (CEA) level, patients with a persistently high serum CEA level after surgery have been reported to have a poor prognosis. In addition, in other cancers, the post/preoperative serum CEA ratio has been reported as a useful parameter.
MATERIALS AND METHODS: We enrolled 123 NSCLC patients with preoperative high CEA levels (≥ 5 ng/mL) who underwent curative surgery between 2004 and 2011. Prognostic significance of postoperative serum CEA level and the CEA ratio was examined.
RESULTS: The 5-year survival of patients with persistently high serum CEA level after surgery was poor. On the other hand, patients with normal postoperative serum CEA levels had significant favorable prognosis. The patients with CEA ratio>1 had poor prognosis, however the number was only 7 (5.7%). The 5-year survival rates of patients with other subgroup based on the CEA ratio (0.5 ≥ CEA ratio and 0.5 ≤ CEA ratio ≤ 1) was similar. Multivariate analysis revealed prognostic significance for the postoperative serum CEA level but not the CEA ratio.
CONCLUSIONS: For NSCLC patients with preoperative high serum CEA level, their postoperative serum CEA levels is a more significant prognostic factor than the post/preoperative serum CEA ratio.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26625802     DOI: 10.7314/apjcp.2015.16.17.7809

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancer.

Authors:  R Zhang; X Zhang; B Ma; B Xiao; F Huang; P Huang; C Ying; T Liu; Y Wang
Journal:  Cancer Gene Ther       Date:  2016-04-15       Impact factor: 5.987

2.  Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.

Authors:  Zhibo Zhang; Fang Yuan; Runzhe Chen; Ye Li; Junxun Ma; Xiang Yan; Lijie Wang; Fan Zhang; Haitao Tao; Dong Guo; Zhiyue Huang; Sujie Zhang; Xiaoyan Li; Xiaoyu Zhi; Xiangwei Ge; Yi Hu; Jinliang Wang
Journal:  Front Immunol       Date:  2020-06-10       Impact factor: 7.561

3.  Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients.

Authors:  Danian Dai; Bo Chen; Hailin Tang; Bin Wang; Zhiping Zhao; Xiaoming Xie; Weidong Wei
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

4.  Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?

Authors:  Qixian Yang; Ping Zhang; Rongqiang Wu; Kefeng Lu; Hongxing Zhou
Journal:  Dis Markers       Date:  2018-10-01       Impact factor: 3.434

5.  The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels.

Authors:  Hai-Lun Xie; Yi-Zhen Gong; Jia-An Kuang; Feng Gao; Shuang-Yi Tang; Jia-Liang Gan
Journal:  Cancer Manag Res       Date:  2019-08-07       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.